IRIS
TINI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.702
EU - Europa 4.215
AS - Asia 2.906
SA - Sud America 577
AF - Africa 187
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.598
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.594
RU - Federazione Russa 1.075
CN - Cina 882
GB - Regno Unito 881
SG - Singapore 849
IT - Italia 572
IE - Irlanda 517
BR - Brasile 465
VN - Vietnam 425
HK - Hong Kong 254
DE - Germania 243
SE - Svezia 228
UA - Ucraina 209
FR - Francia 188
KR - Corea 143
FI - Finlandia 118
ZA - Sudafrica 110
IN - India 105
ES - Italia 56
CA - Canada 49
AR - Argentina 39
TR - Turchia 39
BD - Bangladesh 35
MX - Messico 35
NL - Olanda 29
IQ - Iraq 22
JP - Giappone 22
PL - Polonia 19
BE - Belgio 18
ID - Indonesia 17
PK - Pakistan 17
AT - Austria 16
UZ - Uzbekistan 16
EC - Ecuador 15
NG - Nigeria 15
CO - Colombia 14
IR - Iran 13
KE - Kenya 12
MA - Marocco 12
PY - Paraguay 11
CL - Cile 10
LT - Lituania 10
SA - Arabia Saudita 10
VE - Venezuela 10
TN - Tunisia 9
AU - Australia 8
ET - Etiopia 8
JM - Giamaica 8
IM - Isola di Man 7
JO - Giordania 7
DZ - Algeria 6
NP - Nepal 6
TH - Thailandia 6
UY - Uruguay 6
MY - Malesia 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CI - Costa d'Avorio 4
EG - Egitto 4
HN - Honduras 4
BH - Bahrain 3
BO - Bolivia 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
GA - Gabon 3
IL - Israele 3
PA - Panama 3
PE - Perù 3
RO - Romania 3
TT - Trinidad e Tobago 3
AL - Albania 2
BB - Barbados 2
BG - Bulgaria 2
BW - Botswana 2
BY - Bielorussia 2
GR - Grecia 2
HR - Croazia 2
HU - Ungheria 2
KZ - Kazakistan 2
NO - Norvegia 2
OM - Oman 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
NI - Nicaragua 1
PR - Porto Rico 1
PS - Palestinian Territory 1
Totale 12.592
Salva come PNG Salva come JPEG
Città #
Southend 725
Dallas 547
Dublin 506
Singapore 482
Fairfield 371
Ashburn 350
Moscow 323
Santa Clara 264
San Jose 253
Chandler 247
Hong Kong 239
Beijing 226
Hefei 214
Woodbridge 168
Wilmington 167
Ann Arbor 166
Jacksonville 164
Seattle 147
Houston 142
Seoul 142
Ho Chi Minh City 139
Siena 131
New York 108
Cambridge 106
Johannesburg 102
Menlo Park 98
Hanoi 88
Los Angeles 84
Council Bluffs 83
Princeton 71
The Dalles 69
Milan 64
Munich 64
Florence 62
Rome 59
Lauterbourg 56
Helsinki 55
Nanjing 52
Dearborn 45
Fremont 43
Buffalo 39
Shanghai 34
Málaga 33
Orem 30
London 29
São Paulo 29
Boardman 27
Bengaluru 24
Izmir 24
Tianjin 24
Nuremberg 23
Dong Ket 22
San Diego 22
Redondo Beach 21
Tokyo 21
Chennai 20
Da Nang 20
San Mateo 20
Chicago 19
Frankfurt am Main 19
Brussels 18
Montreal 17
Shenyang 17
Turku 17
Brooklyn 16
Guangzhou 16
Phoenix 16
Stockholm 16
Columbus 15
Haiphong 15
Abuja 14
Mexico City 14
Rio de Janeiro 14
Warsaw 14
Manchester 13
Mumbai 13
Atlanta 12
Lappeenranta 12
Nanchang 12
Tashkent 12
Amsterdam 11
Belo Horizonte 11
Kunming 11
Palermo 11
San Francisco 11
Toronto 11
Brasília 10
Hebei 10
Jinan 10
Poplar 10
Barnet 9
Changsha 9
Dhaka 9
Falkenstein 9
Turin 9
Vienna 9
Zhengzhou 9
Baghdad 8
Biên Hòa 8
Espoo 8
Totale 8.408
Salva come PNG Salva come JPEG
Nome #
3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures 362
Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS) 320
Trehalose inhibits cell proliferation and amplifies long-term temozolomide- and radiation-induced cytotoxicity in melanoma cells: A role for autophagy and premature senescence 300
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 299
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 296
Diffusion-weighted magnetic resonance diagnosis of local recurrences of prostate cancer after radical prostatectomy: preliminary evaluation on twenty-seven cases 282
Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy 273
Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT 272
Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells 269
Epidermal Growth Factor Receptor Expression predicts Time and Patterns of Recurrence in Glioblastoma Patients Following Radiotherapy and Temozolomide. 254
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 254
Beta-catenin and Gli1 are prognostic markers in glioblastoma 245
Bone structure texture analysis as a potential tool to estimate radiation induced insufficiency fracture risk. 234
Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and Temozolomide combined treatments 226
Beta-Catenin and Gli-1 as prognostic markers in Glioblastoma Multiforme. 219
Autofagia nei gliomi HG: analisi ed interpretazione di dati clinici e biologici 219
Diffusion-weighted MR volumetry for assessing the response of rectal cancer to combined radiation therapy with chemotherapy 218
A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case report 215
Texture analysis of parotid gland as a predictive factor of radiation induced xerostomia: A subset analysis 212
Tumor infiltration by T lymphocytes correlates with the outcome of prostate cancer patients treated with salvage radiotherapy 209
The effects of radiotherapy on the survival of patients with unresectable non-small cell lung cancer 199
The prognostic role of Beclin 1 protein expression in high-grade gliomas 194
Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status 192
Clinical radiobiology of glioblastoma multiforme: estimation of tumor control probability from various radiotherapy fractionation schemes 191
Combining Ipilimumab and Bevacizumab in Glioblastoma is Really Safe and Effective? 188
Is there a potential role for EGFR expression to lead margin reduction in glioblastoma? 187
Delta-radiomics and response to neoadjuvant treatment in locally advanced gastric cancer-a multicenter study of GIRCG (Italian Research Group for Gastric Cancer) 176
Challenges and Opportunities in Accessing Surgery for Glioblastoma in Low–Middle Income Countries: A Narrative Review 166
Bone texture analysis using CT-simulation scans to individuate risk parameters for radiation-induced insufficiency fractures. 163
Cyclin D1 Co-localizes with Beclin-1 in Glioblastoma Recurrences: A Clue to a Therapy-induced, Autophagy-mediated Degradative Mechanism? 162
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 161
Single-isocenter multiple-target stereotactic radiosurgery for multiple brain metastases: dosimetric evaluation of two automated treatment planning systems 157
Combined epidermal growth factor receptor and beclin1 autophagic protein expression analysis identifies different clinical presentations, responses to chemo- and radiotherapy, and prognosis in glioblastoma 153
Feasibility of clinical target volume reduction for glioblastoma treated with standard chemoradiation based on patterns of failure analysis 152
Epidermal Growth Factor Receptor Expression May Correlate with Survival Through Clinical and Radiological Features of Aggressiveness in Glioblastoma Treated with Radiochemotherapy 146
Correction to: Predictive value of perilesional edema volume in melanoma brain metastasis response to stereotactic radiosurgery (Journal of Neuro-Oncology, (2024), 10.1007/s11060-024-04818-9) 144
Three-dimensional conformal radiotherapy, temozolomide chemotherapy, and high-dose fractionated boost in a protocol-driven, postoperative treatment schedule for high-grade gliomas 140
null 139
Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab 136
The combined EGFR protein expression analysis refines the prognostic value of the MGMT promoter methylation status in glioblastoma. 133
In Regard to Kubicek et al. 131
null 130
Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation. 128
null 126
Radiation therapy for atypical and anaplastic meningiomas: an overview of current results and controversial issues 125
Predictive value of perilesional edema volume in melanoma brain metastasis response to stereotactic radiosurgery 121
Abscopal Effect on Bone Metastases from Solid Tumors: A Systematic Review and Retrospective Analysis of Challenge within a Challenge 119
null 117
null 116
Serum lactate dehydrogenase as a prognostic marker for treatment response in IDH wild-type glioblastoma patients undergoing stupp protocol 116
Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade 112
Comment on “Everolimus induces G1 cell cycle arrest through autophagy-mediated protein degradation of cyclin D1 in breast cancer cells” 112
The role of delta radiomics in gastric cancer 109
Persistent hiccup after chemo-radiotherapy in nasopharyngeal cancer: an atypical side effect? 108
Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival? 107
Long-term treatment outcomes of temozolomide-based chemoradiation in patients with adult-type diffuse IDH-mutant grade 2 astrocytoma 104
Magnetic-resonance-imaging texture analysis predicts early progression in rectal cancer patients undergoing neoadjuvant chemoradiation 101
Automatic genetic planning for volumetric modulated arc therapy: A large multi-centre validation for prostate cancer 99
null 98
Clinically relevant radioresistant rhabdomyosarcoma cell lines: Functional, molecular and immune-related characterization 98
Current status and perspectives of interventional clinical trials for brain metastases: analysis of ClinicalTrials.gov 92
Biomolecular Predictors of Recurrence Patterns and Survival in IDH-Wild-Type Glioblastoma: A Retrospective Analysis of Patients Treated with Radiotherapy and Temozolomide 92
Watch the Mass, Save the Gland (Radiation Therapy Perhaps Later) 92
Inflammatory markers and procalcitonin predict the outcome of metastatic non-small-cell-lung-cancer patients receiving PD-1/PD-L1 Immune-Checkpoint Blockade 88
Role of perilesional edema and tumor volume in the prognosis of non-small cell lung cancer (NSCLC) undergoing radiosurgery (SRS) for brain metastases 85
Letter to the Editor: Commentary on “Bevacizumab Alone Versus Bevacizumab Plus Irinotecan in Patients With Recurrent Glioblastoma” 84
Delta-radiomics increases multicentre reproducibility: a phantom study 83
The evolving role of reirradiation in the management of recurrent brain tumors 83
null 83
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines 82
null 82
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO 81
NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance 78
Stereotactic radiotherapy for brain oligometastases 77
Assessing ChatGPT-4 as a clinical decision support tool in neuro-oncology radiotherapy: a prospective comparative study 77
How to Increase the Efficacy of Immunotherapy in NSCLC and HNSCC: Role of Radiation Therapy, Chemotherapy, and Other Strategies 77
Stereotactic radiosurgery for the treatment of brainstem metastases: a multicenter retrospective study 75
Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation 74
Multimodality Imaging Assessment of Malignant Pleural Mesothelioma 74
Music therapy and radiation oncology: State of art and future directions 71
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 64
Tips and tricks of spinal cord biopsy: insights from a multicenter series of 61 patients 62
Role of the Appropriateness of the Pelvic Lymphadenectomy and Adjuvant Radiation Therapy in Early-Stage Poorly Differentiated Endometrial Carcinoma 62
Tumors of the optic nerve and its sheath 61
Cell Death Pathways, with Special Regard to Ionizing Radiation and Temozolomide 55
Perilesional edema in brain cancer: Independent prognosticator or epiphenomenon of biomolecular signature? 53
Clinical, Pathological, and Molecular Prognostic Parameters in Glioblastoma Patients Undergoing Chemo- and Radiotherapy 48
Timing matters: overall treatment time, radiotherapy interruptions, and outcomes in glioblastomas—prognostic significance in different biological sub-groups 40
miRNA Manipulation in Modifying Radiation Sensitivity in Glioblastoma Models 17
Mathematical Modelling of Radiobiological Parameters 15
Totale 12.841
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.510
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021209 0 0 0 0 0 0 0 0 0 87 46 76
2021/2022567 52 59 42 42 42 31 26 30 27 50 55 111
2022/2023874 47 74 130 113 79 155 23 71 80 44 27 31
2023/2024866 22 19 82 54 36 223 337 15 7 19 18 34
2024/20252.070 64 71 174 87 191 254 58 147 119 93 215 597
2025/20265.295 436 701 529 776 1.180 221 703 187 169 393 0 0
Totale 12.841